Nigeria has launched its first immunotherapy trial for colorectal cancer. The trial represents a new frontier in cancer treatment research within the country. No further details about the trial's location, participants, or timeline are available at this time. The development is a notable milestone for Nigeria's healthcare and medical research sectors. It signals a move towards exploring advanced treatment options for serious diseases locally. The full scope and potential impact of this trial will become clearer as it progresses.